7-2433181-T-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_018641.5(CHST12):c.542T>A(p.Val181Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018641.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHST12 | NM_018641.5 | c.542T>A | p.Val181Glu | missense_variant | Exon 2 of 2 | ENST00000618655.2 | NP_061111.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHST12 | ENST00000618655.2 | c.542T>A | p.Val181Glu | missense_variant | Exon 2 of 2 | 1 | NM_018641.5 | ENSP00000481912.1 | ||
CHST12 | ENST00000258711.7 | c.542T>A | p.Val181Glu | missense_variant | Exon 2 of 2 | 1 | ENSP00000258711.6 | |||
CHST12 | ENST00000432336.1 | c.542T>A | p.Val181Glu | missense_variant | Exon 2 of 2 | 2 | ENSP00000411207.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000800 AC: 2AN: 249934Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135460
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460770Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 726726
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152100Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.542T>A (p.V181E) alteration is located in exon 2 (coding exon 1) of the CHST12 gene. This alteration results from a T to A substitution at nucleotide position 542, causing the valine (V) at amino acid position 181 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at